FDA Drug Safety Communication: FDA study of Medicare patients finds risks lower for stroke and death but higher for gastrointestinal bleeding with Pradaxa (dabigatran) compared to warfarin. FDA Drug Safety Communication - Communication FDS (2014)
Accessed July 11, 2014.